M. Kathleen Behrens - Nov 8, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Nov 8, 2022
Transactions value $
$1,028,550
Form type
4
Date filed
11/10/2022, 04:10 PM
Previous filing
Oct 3, 2022
Next filing
Dec 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Purchase $1.03M +60K +37.93% $17.14 218K Nov 8, 2022 See footnote F1, F2
holding IGMS Common Stock 3.39K Nov 8, 2022 Direct
holding IGMS Common Stock 29.8K Nov 8, 2022 See footnote F3
holding IGMS Common Stock 29.8K Nov 8, 2022 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $16.94 to $17.25. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
F2 The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee.
F3 The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
F4 The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.